Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Alaunos Therapeutics, Inc. (TCRT) had Weighted-Average Shares Outstanding (Diluted) of 1.95M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-1.01M |
|
-- |
|
-- |
|
$1.01M |
|
$-1.01M |
|
$0.01M |
|
$-1.01M |
|
$-1.01M |
|
$-1.01M |
|
$-1.01M |
|
$-1.01M |
|
$-1.01M |
|
$-1.01M |
|
$-1.00M |
|
1.95M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
1.95M |
$-0.59 |
|
$-0.59 |
|
| Balance Sheet Financials | |
$0.97M |
|
$0.08M |
|
$0.91M |
|
$1.88M |
|
$0.59M |
|
-- |
|
-- |
|
$0.59M |
|
$1.29M |
|
$1.29M |
|
$1.29M |
|
2.38M |
|
| Cash Flow Statement Financials | |
$-1.03M |
|
$0.00M |
|
$0.00M |
|
$1.39M |
|
$0.35M |
|
$-1.03M |
|
$0.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.63 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.03M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-78.10% |
|
-78.11% |
|
-53.43% |
|
-78.11% |
|
$0.54 |
|
$-0.53 |
|
$-0.53 |
|